Clascoterone

DB12499ApprovedInvestigationalSmall moleculeAndrogen Receptor Inhibitors

Clascoterone is an androgen receptor antagonist used for the topical treatment of acne vulgaris in patients 12 years of age and older. Clascoterone (cortexolone 17α-propionate, CB-03-01) is a novel antagonist of androgen receptors.

Chemical structure of Clascoterone
Mechanism
Curator reviewed · 5 references
Primary indication
Clascoterone is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.Curator reviewed · 1 structured indication
Formula / weight
C24H34O5 · 402.531 g/mol (avg)
First approval
Canada, 2023 · United States, 2021 · European Union, 2026
Also known as
Cortexolone 17alpha-propionate
Code names
CB-03-01
Brand names
  • Winlevi

Resolves to

Structure
InChIKeyGPNHMOZDMYNCPO-PDUMRIMRSA-NSMILES[H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Targets

What you can answer from here — as of June 27, 2023

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Drug interactionStructured to mechanism, not free text
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
5Marketed productsAcross 3 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 38 drug categories
Sign in
24+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Clascoterone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account